Sam Jaffe | Mar 14, 2004 | 2 min read
Compiled by Sam JaffeCancer vaccine therapies continue to inch toward approval. Even with the complex regulations controlling biologics and cell based techniques, over 100 such treatments are undergoing clinical trials, with more than a dozen in Phase III trials. The underlying mechanisms vary widely, but they share the goal of boosting the immune system to attack pre-existing tumors. Here are four examples of formulations that have shown some promise.Cytokine Vaccine: A whole-cell vaccine calle